Do Not Wait—Start Treatment Immediately
For a blood pressure of 168/110 mmHg, you should start antihypertensive drug therapy immediately along with lifestyle interventions, even on the first visit, after confirming the diagnosis with repeat measurements during that same visit or within 2-3 office visits. This reading qualifies as Grade 2 hypertension (≥160/100 mmHg), which mandates prompt pharmacological treatment regardless of cardiovascular risk factors 1.
Diagnostic Confirmation First
Before initiating treatment, confirm the diagnosis properly:
- Take multiple readings at the initial visit: Use the average of 2-3 readings taken during the same visit with a validated automated device and appropriate cuff size 1
- Confirm over 2-3 office visits: The 2020 ISH guidelines specify that BP ≥140/90 mmHg should be remeasured in 2-3 office visits to establish the diagnosis 1
- Consider out-of-office monitoring if feasible: Home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg confirms hypertension 1
However, for BP ≥180/110 mmHg, the 2024 ESC guidelines recommend assessment for hypertensive emergency and prompt confirmation within a week before starting treatment (unless emergency exists) 2. Your patient at 168/110 mmHg falls just below this threshold but still requires urgent action.
Why Immediate Treatment Is Critical
Grade 2 hypertension (≥160/100 mmHg) requires immediate drug therapy because delays in treatment increase cardiovascular disease event rates 2. The evidence is unequivocal:
- At this BP level, the absolute cardiovascular risk is sufficiently elevated that the benefits of treatment clearly outweigh any risks
- The 2020 ISH guidelines explicitly state "Start drug treatment immediately" for Grade 2 hypertension 1
- The 2017 ACC/AHA guidelines recommend prompt antihypertensive drug treatment for very high BP (SBP ≥180 or DBP ≥110 mmHg), and your patient's diastolic of 110 mmHg meets this threshold 3
Treatment Approach
Start combination therapy with 2 first-line agents from different classes:
For non-Black patients:
- Low-dose ACEI/ARB + DHP calcium channel blocker, OR
- Low-dose ACEI/ARB + thiazide/thiazide-like diuretic 1
For Black patients:
- Low-dose ARB + DHP calcium channel blocker, OR
- DHP calcium channel blocker + thiazide/thiazide-like diuretic 1
Simultaneously initiate lifestyle interventions:
- Sodium restriction to <1500 mg/day
- DASH diet (rich in fruits, vegetables, whole grains, low-fat dairy)
- Weight loss if overweight (target ≥1 kg reduction)
- Physical activity (90-150 min/week aerobic exercise)
- Alcohol moderation (≤2 drinks/day men, ≤1/day women)
- Smoking cessation 4
Common Pitfalls to Avoid
Do not delay treatment waiting for multiple office visits when BP is ≥160/100 mmHg. While confirmation is important, the 2020 ISH guidelines are clear that drug treatment should start immediately for Grade 2 hypertension 1. You can confirm the diagnosis over 2-3 visits while simultaneously initiating therapy.
Do not start with monotherapy at this BP level. When BP is >20/10 mmHg above target (and your patient is 28/20 mmHg above the 140/90 target), combination therapy is more effective and achieves control faster 3, 5.
Do not assume this is white coat hypertension without confirmation. While white coat hypertension exists, a diastolic BP of 110 mmHg is less likely to be artifactual. If there's genuine concern, use home or ambulatory BP monitoring to confirm, but don't withhold treatment in the interim for Grade 2 hypertension 3.
Follow-Up Timeline
- Recheck BP in 1 month after initiating treatment 3
- Target BP <140/90 mmHg (or <130/80 mmHg if high cardiovascular risk) 1
- Achieve target within 3 months of treatment initiation 1
- Assess for secondary hypertension causes and target organ damage as clinically indicated 1
The key distinction is that Grade 1 hypertension (140-159/90-99 mmHg) allows for risk stratification—treating high-risk patients immediately and low-risk patients after 3-6 months of lifestyle intervention. Your patient's BP of 168/110 mmHg eliminates this decision tree entirely: immediate drug therapy is indicated regardless of other risk factors 1.